Physicians assistants; Pharmacy Act; prescriptions for controlled dangerous substances; Physician Assistant Act; Committee; members; requirements; Public Health Code; authority for physician assistants to carry out certain functions; prescribing and administering controlled substances; supervision.
HB2584 revises Oklahoma law governing physician assistants, pharmacy dispensing, and controlled dangerous substances. The bill updates definitions in the Oklahoma Pharmacy Act and Physician Assistant Act, expands the Physician Assistant Committee from seven to nine members, and clarifies how physician assistants may practice, including under practice agreements and under supervision of delegating physicians. It also creates a process for physician assistants to report completion of 6,240 hours of postgraduate clinical practice experience to the State Board of Medical Licensure and Supervision, after which they are no longer required to practice under a delegating physician’s supervision, though they may still maintain a practice agreement if they choose.
The bill also expands and clarifies prescribing authority. It allows physician assistants, subject to registration and statutory limits, to prescribe and administer controlled dangerous substances in Schedules II through V, and it updates pharmacy law so pharmacists may dispense certain prescriptions written by physician assistants. In addition, it amends death-certificate law to recognize physician assistants in the medical certification process and updates controlled-substance definitions to reflect physician assistant authority. The bill repeals a prior section governing physician supervision and practice agreements, replacing it with a more detailed framework.
HB2584 appears to have broad support overall, but it was not unanimous. It passed several committee and floor votes with clear majorities, including strong House and Senate votes on third reading and veto override, indicating that most lawmakers supported the measure’s modernization of physician assistant practice rules. The bill’s emergency clause also passed the House, suggesting an intent to make the changes effective quickly.
The main point of contention is the degree of independence granted to physician assistants. Supporters appear to favor greater flexibility, reduced administrative barriers, and expanded access to care, especially by allowing experienced physician assistants to practice without direct supervision after meeting the 6,240-hour threshold. Opponents likely focused on patient-safety and oversight concerns, particularly around prescribing controlled substances, the reduced supervision requirement, and the shift away from mandatory practice agreements for experienced physician assistants. The committee and floor vote margins show some resistance, but not enough to stop the bill.
HB2584 amends multiple sections of Titles 59 and 63 of the Oklahoma Statutes, primarily affecting the Oklahoma Pharmacy Act, the Physician Assistant Act, the Uniform Controlled Dangerous Substances Act, and death-certificate certification rules. It changes who may prescribe and dispense certain medications, expands the role of physician assistants in clinical practice and controlled-substance prescribing, requires the Board of Medical Licensure and Supervision to maintain reporting lists and forms, and removes the prior statutory section on physician supervision and practice agreements. The bill directly affects physician assistants, supervising/delegating physicians, pharmacists, the State Board of Medical Licensure and Supervision, the State Board of Pharmacy, and death-certificate certifiers.
The overall sentiment reflected in the votes is favorable, with the bill advancing through committee and floor votes in both chambers and ultimately surviving veto override votes. The margins suggest that lawmakers generally viewed the bill as a needed update to professional practice rules for physician assistants and pharmacy-related prescribing authority. At the same time, the nontrivial number of no votes indicates meaningful concern about the scope of the changes, especially the supervision and prescribing provisions.
The most notable contention centers on whether physician assistants should be allowed to practice with less direct physician supervision after accumulating 6,240 postgraduate clinical hours, and whether they should be authorized to prescribe Schedule II through V controlled substances under the bill’s framework. Critics likely worried about oversight, accountability, and patient safety, while supporters emphasized workforce flexibility and expanded access to care. Additional friction may have involved the expansion of the Physician Assistant Committee and the administrative changes to reporting, but the supervision and controlled-substance provisions are the clearest substantive points of disagreement.